Novavax, Inc. (NASDAQ:NVAX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.

Recs

0
Player Avatar Brian7992 (< 20) Submitted: 8/11/2009 2:29:09 PM : Outperform Start Price: $4.78 NVAX Score: -106.25

Like this one 2

Featured Broker Partners


Advertisement